Therapy-related leukemia and myelodysplastic syndrome in breast cancer patients treated with cyclophosphamide or anthracyclines

Japanese Journal of Clinical Oncology

Volumn 29, Issue 1, 1999, Pages 28-32

  Ando, Masashi ^a   Narabayashi, Masaru ^a   Watanabe, Toru ^a   Kamiya, Yoshikazu ^a   Togitani, Kazuto ^a   Tanosaki, Ryuji ^a   Takenaka, Takeaki ^a   Tobinai, Kensei ^a   Adachi, Isamu ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Breast cancer; Cyclophosphamide; Myelodysplastic syndrome; Therapy related leukemia

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; AGED; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; LEUKEMIA; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; SECOND CANCER;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LEUKEMIA; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY;

EID: 0032603981     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.1.28     Document Type: Article

References (23)

1. Coleman CW, Williams C, Flint A, Glastein EJ, Rosenberg SA, Kaplan HS. Hematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med 1977;297:1249-52.
2. Vardiman J, Golomb H, Rowley J, Varikojis D. Acute non-lymphocytic leukemia in malignant lymphoma. Cancer 1978;42:229-42.
3. Ratain MJ, Kaminer LS, Bitran JD, Larson RA, Le Beau MM, Skose YC. Acute nonlymphocytic leukemia following etoposide and cisplatinum combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood 1987;70:1412-7.
4. Pui CH, Behm FG, Raimondi SC, Dodge RK, George SL, Rivera GK. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 1989;321:136-42.
5. Reimer RR, Hoover R, Fraumeni JF Jr, Young RC. Acute leukemia after alkylating-agent therapy of ovarian cancer. N Engl J Med 1977;297:177-81.
6. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes No. 5 and 7. J Clin Oncol 1986;4:325-45.
7. Kantarjian HM, Keating MJ, Walters RS, Smith TL, Cork A, McCredie KB. Therapy-related leukemias and myelodysplastic syndrome: clinical cytogenetics and prognostic features. J Clin Oncol 1986;4:1748-57.
8. Pedersen-Bjergaard J, Sigsgaard T, Nielsen D, Gjedde SB, Philip P, Hansen M. Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer. J Clin Oncol 1992;10:1444-51.
9. Ratain MJ, Rovvley JD. Therapy related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes. Ann Oncol 1992;3:107-11.
10. Riggi M, Riva A. Therapy related leukemia. What is the role of 4-epi-doxorubucin? J Clin Oncol 1993;11:1430-1.
11. Sandoval C, Pui C-H, Bowman LC, Heaton D, Hurwitz CA, Raimondi SC. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors and irradiation. J Clin Oncol 1993;11:1039-45.
12. Fisher B, Rockette H, Fisher ER, Wickerham DL, Redmond C, Brown A. Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. J Clin Oncol 1985;3:1640-58.
13. Geller RB, Bonne LB, Karp JE, Davidson N, Selonick SE, Edwards J. Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma: a new complication of cyclophosphamide, methotrexate and 5-fluorouracil therapy. Cancer 1989;64:629-34.
14. Curtis RE, Boice JD Jr, Stovall M, Bernstein L, Greenberg, RS, Flannery JT. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 1992;326:1745-51.
15. Valagussa P, Molitemi A, Terenziani M, Zambetti M, Bonadonna G. Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer. Ann Oncol 1994;5:803-8.
16. Tallman MS, Gray R, Bennett JM, Variakojis D, Robert N, Wood WC. Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience. J Clin Oncol 1995;13:1557-63.
17. Diamandidou E, Buzdar AU, Smith TL, Frye D, Witjaksono M, Hortobagyi GN. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol 1996;14:2722-30.
18. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnic HR The French-American-British (FAB) Cooperative Group: proposals for the classification of the acute leukemias. Br J Haematol 1976;33:451-8.
19. 19: Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnic HR. The French-American-British (FAB) Cooperative Group: proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-99.
20. Boice JD, Greene MH, Killen JY Jr, Ellenberg SS, Fraumeni JF Jr, Keehn RJ. Leukemia after adjuvant chemotherapy with semustine - Evidence of dose-response effect. N Engl J Med 1986;314:119-20.
21. Pizzolo G, Molino A, Sabbioni R, Cetto GC, Iannucci A, Chilos M. Acute lymphoblastic leukemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. Acta Haematol 1981;65:128-30.
22. Pedersen-Bjergaard J, Philip P, Larsen SO, Jensen G, Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 1990;76:1083-91.
23. Kantavjian HM, Estey EH, Keating MJ. Treatment of therapy-related leukemia and myelodysplastic syndrome. Haematol Oncol Clin N Am 1993;7:81-107.